购物车
- 全部删除
- 您的购物车当前为空
Ulixertinib (VRT752271) 是一种有效且可逆的 ERK1/ERK2 抑制剂,可抑制 ERK2 和下游蛋白 RSK 的磷酸化,对 ERK2 的IC50值小于 0.3 nM。
Ulixertinib (VRT752271) 是一种有效且可逆的 ERK1/ERK2 抑制剂,可抑制 ERK2 和下游蛋白 RSK 的磷酸化,对 ERK2 的IC50值小于 0.3 nM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 335 | 现货 | |
2 mg | ¥ 477 | 现货 | |
5 mg | ¥ 822 | 现货 | |
10 mg | ¥ 1,330 | 现货 | |
25 mg | ¥ 2,390 | 现货 | |
50 mg | ¥ 3,990 | 现货 | |
100 mg | ¥ 5,680 | 现货 | |
200 mg | ¥ 7,930 | 现货 | |
500 mg | 询价 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 861 | 现货 |
产品描述 | Ulixertinib (VRT752271) (BVD-523, VRT752271) is an effective and reversible ERK1/ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2. |
靶点活性 | ERK2:<0.3 nM |
体外活性 | 在含有b-RAFV600E突变的A375黑色素瘤细胞株中,Ulixertinib分别以IC50为4.1/0.14 μM降低磷酸化ERK2(pERK)和下游激酶RSK(pRSK)的水平。同时,Ulixertinib以IC50为180 nM抑制A375细胞的增殖。[1] |
激酶实验 | ERK2 Rapidfire Mass Spectrometry Inhibition of Catalysis Assay: MEK U911-activated ERK2 protein is expressed and purified in-house. Enzyme and substrate solutions are made up in assay buffer consisting of 50 mM Tris (pH 7.5), 10 mM MgCl2, 0.1 mM EGTA, 10 mM DTT and 0.01% (v/v) CHAPS. 1.2 nM ERK2 protein is prepared in assay buffer and 10 μL is dispensed into each well of a polypropylene, 384-well plate containing test and reference control compounds. The compound plates had previously been dosed with a 12 point range from 100 μM down to 0.1 nM in order to calculate compound IC50s, with a total DMSO concentration in the assay of 1%. Following a 20 minute pre-incubation of enzyme and compound at room temperature, 10 μL of substrate solution is added consisting of 16 μM Erktide (IPTTPITTTYFFFK) and 120 μM ATP (measured Km) in assay buffer. The reaction is allowed to progress for 20 minutes at room temperature before being quenched by the addition of 80 μl 1% (v/v) formic acid. The assay plates are then run on the RapidFire Mass Spectrometry platform to measure substrate (unphosphorylated Erktide) and product (phosphorylated Erktide) levels. |
细胞实验 | A375 cells are cultured in cell media composed of DMEM, 10% (v/v) Foetal Calf Serum and 1% (v/v) L-Glutamine. After harvesting, cells are dispensed into black, 384-well Costar plates to give 200 cells per well in a total volume of 40 μL cell media, and are incubated overnight at 37°C, 90% relative humidity and 5% CO2 in a rotating incubator. Test compounds and reference controls are dosed directly into the cell plates, into the inner 308 wells, using a Labcyte Echo 555 acoustic dispenser. The cells are dosed over a 12 point range from 30 μM down to 0.03 nM in order to calculate compound IC50s, with a total DMSO concentration in the assay of 0.3%. The cell plates are then incubated for 72 hours at 37°C. Cells were fixed and stained by the addition of 20 μL 12% formaldehyde in PBS/A (4% final concentration) and 1:2000 dilution of Hoechst 33342, with a 30 minute room temperature incubation, and then washed with PBS/A. A cell count is performed on the stained cell plates using a Cellomics ArrayScanTM VTI imaging platform. A Day 0 cell plate is also fixed, stained and read to generate a cell count baseline for determining compound cytotoxic effects as well as anti-proliferative effects.(Only for Reference) |
别名 | BVD-523, 优立替尼, VRT752271 |
分子量 | 433.33 |
分子式 | C21H22Cl2N4O2 |
CAS No. | 869886-67-9 |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||||||||||||
溶解度信息 | H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 70 mg/mL (161.54 mM) 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 8 mg/mL (18.46 mM), Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. Ethanol: 12 mg/mL (27.7 mM) | |||||||||||||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||||||||||||
10% DMSO+40% PEG300+5% Tween 80+45% Saline/Ethanol/DMSO
Ethanol/DMSO
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.